Novolog (Pharm-Up 1966) Ltd (TLV:NVLG)

Novolog (Pharm-Up 1966) Balance Sheet

Financials in millions ILS. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	111.22	247.6	232.94	172.81	238.71	176.44
Cash & Short-Term Investments	111.22	247.6	232.94	172.81	238.71	176.44
Cash Growth	-44.09%	6.29%	34.80%	-27.61%	35.29%	-4.68%
Accounts Receivable	1,806	1,744	1,560	1,310	1,286	1,260
Other Receivables	115.3	46.62	53.43	36.54	20.28	10.99
Receivables	1,922	1,790	1,613	1,346	1,306	1,271
Inventory	415.83	315.08	247.33	189.03	186.79	255.64
Prepaid Expenses	-	7.57	11.35	9.56	10.25	4.68
Other Current Assets	6.32	1.94	1.86	0.76	-	-
Total Current Assets	2,455	2,362	2,106	1,719	1,742	1,708
Property, Plant & Equipment	287.18	297.54	321.4	306.62	224.77	191.24
Long-Term Investments	13.95	13.61	16.2	42.31	23.4	0.5
Goodwill	156.2	156.2	162.69	206.96	161.06	144.91
Other Intangible Assets	165.33	159.25	138.43	121.92	97.4	75.78
Long-Term Accounts Receivable	25.92	26.11	29.62	32.15	33.94	34.93
Long-Term Deferred Tax Assets	5.23	3.74	4.82	1.78	0.77	1.04
Other Long-Term Assets	8.5	18.15	9	6.29	5.04	30.2
Total Assets	3,117	3,037	2,789	2,437	2,289	2,187
Accounts Payable	2,429	2,357	2,079	1,662	1,616	1,663
Accrued Expenses	-	64.5	56.53	49.43	43.48	32.97
Current Portion of Long-Term Debt	-	-	0.91	1.15	0.39	0.06
Current Portion of Leases	25.13	21.31	26.6	22.06	20.14	16.2
Current Income Taxes Payable	5.94	6.03	6.55	6.52	4.59	2.61
Other Current Liabilities	94.91	11.32	15.65	13.42	4.3	18.39
Total Current Liabilities	2,555	2,460	2,185	1,754	1,689	1,734
Long-Term Debt	-	-	0.07	0.97	0.92	0.43
Long-Term Leases	165.95	177.16	187.59	188.6	145.37	137.54
Long-Term Deferred Tax Liabilities	9.69	12.94	16.41	19.71	17.63	16.22
Other Long-Term Liabilities	1.18	3.52	1.69	6.46	1.42	0.5
Total Liabilities	2,733	2,655	2,392	1,972	1,858	1,891
Common Stock	5.11	5.11	5.11	5.09	5.07	4.64
Additional Paid-In Capital	347.33	347.19	345.07	340.97	339.73	218.91
Retained Earnings	33.22	32.21	32.67	91.58	75.97	65.65
Comprehensive Income & Other	-15.3	-16.13	-11.77	-1.93	3.61	5.49
Total Common Equity	370.37	368.38	371.08	435.7	424.37	294.69
Minority Interest	13.95	13.77	25.04	28.78	5.86	0.98
Shareholders' Equity	384.32	382.14	396.12	464.48	430.23	295.67
Total Liabilities & Equity	3,117	3,037	2,789	2,437	2,289	2,187
Total Debt	191.08	198.47	215.18	212.77	166.81	154.24
Net Cash (Debt)	-79.86	49.13	17.76	-39.97	71.9	22.2
Net Cash Growth	-	176.64%	-	-	223.81%	-18.03%
Net Cash Per Share	-0.16	0.10	0.03	-0.08	0.14	0.05
Filing Date Shares Outstanding	510.89	510.75	510.72	508.7	506.57	463.49
Total Common Shares Outstanding	510.89	510.75	510.72	508.7	506.57	463.49
Working Capital	-99.81	-97.42	-78.39	-35.81	52.94	-25.64
Book Value Per Share	0.72	0.72	0.73	0.86	0.84	0.64
Tangible Book Value	48.84	52.93	69.97	106.82	165.91	74
Tangible Book Value Per Share	0.10	0.10	0.14	0.21	0.33	0.16
Machinery	-	145.73	148.01	131.88	155.63	133.06
Leasehold Improvements	-	134.68	131.41	113.03	74.47	71

Updated Nov 19, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.